Related Experiment Videos

[Pathogenicity of various species of Candida in an experimental murine system]

Insights

Candida albicans causes lethal systemic infections in mice, while Candida krusei is non-pathogenic. Different mouse strains show similar resistance, suggesting non-genic control of infection severity.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Candida species are opportunistic fungal pathogens.
  • Understanding the pathogenicity of different Candida species is crucial for clinical management.
  • Murine models are essential for studying host-pathogen interactions in systemic fungal infections.

Purpose of the Study:

  • To compare the pathogenicity of Candida albicans, Candida krusei, and Candida viswanathii in a murine model.
  • To investigate the role of host genetics in determining resistance to systemic Candida infections.

Main Methods:

  • Intravenous inoculation of outbred CD1 mice with standardized concentrations of Candida albicans, Candida krusei, and Candida viswanathii.
  • Monitoring of survival rates and median survival times.
  • Quantification of colony-forming units (CFU) in murine kidneys at various time points post-infection.
  • Assessment of pathogenicity across different mouse strains (CD1, CD2F1, B6C3HF1, Balb/c).

Main Results:

  • Candida albicans demonstrated high pathogenicity, causing mortality at low concentrations.
  • Candida krusei exhibited no pathogenicity, even at high doses.
  • Candida viswanathii showed pathogenicity only at higher concentrations.
  • No significant differences in resistance were observed across various mouse strains, indicating non-genic control.
  • Kidney CFU counts correlated with survival times, with rapid Candida albicans multiplication observed within 24 hours, unlike Candida krusei and Candida viswanathii.

Conclusions:

  • Candida albicans is significantly more virulent in this murine model compared to Candida krusei and Candida viswanathii.
  • Host genetic factors do not appear to play a major role in determining susceptibility to these Candida species in the tested strains.
  • The in vivo proliferation rate of Candida species in the kidneys is a key determinant of systemic infection outcome.

Related Concept Videos